BCRX

BioCryst Pharmaceuticals (BCRX)

About BioCryst Pharmaceuticals (BCRX)

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Details

Daily high

$7.58

Daily low

$7.11

Price at open

$7.44

52 Week High

$11.31

52 Week Low

$6.00

Market cap

1.6B

Dividend yield

0.00%

Volume

4.7M

Avg. volume

4.0M

P/E ratio

-157.93

BioCryst Pharmaceuticals News